Carolina Eyecare Physicians

$Representative image of artificial intelligence in ophthalmology, illustrating how AI is moving into focus at the ASCRS 2026 Annual Meeting as cataract and refractive surgery leaders assess its clinical, ethical, and commercial future.$

Healthcare Industry News

AI in ophthalmology at ASCRS 2026: What the Washington DC meeting is signalling about the specialty’s technology future

Kerry Solomon's Binkhorst Lecture at ASCRS 2026 in Washington DC puts AI at the centre of ophthalmology. Coverage of Zeiss VisioGen, IOL calculators, and Sean Ianchulev's Kelman Lecture.

byVenkatesh

April 11, 2026

Healthcare Industry News

Alcon launches AcrySof IQ PanOptix trifocal intraocular lens for cataract surgery patients in US

Alcon, a leading global eye care company, has introduced its AcrySof IQ PanOptix trifocal intraocular lens (IOL) in…

bypharmanewsdaily

October 13, 2019

The Latest

Is DLL3 becoming the most strategic biomarker target in neuroendocrine oncology?

realme Buds T310 review: Are these the best budget ANC earbuds under ₹2,000?

Why support-platform strategy may become a differentiator in schizophrenia treatment markets

What gold’s latest rally says about geopolitical hedging after the Strait of Hormuz reopening

AI in ophthalmology at ASCRS 2026: What the Washington DC meeting is signalling about the specialty’s technology future

Alcon launches AcrySof IQ PanOptix trifocal intraocular lens for cataract surgery patients in US

Is DLL3 becoming the most strategic biomarker target in neuroendocrine oncology?

realme Buds T310 review: Are these the best budget ANC earbuds under ₹2,000?

Why support-platform strategy may become a differentiator in schizophrenia treatment markets

What gold’s latest rally says about geopolitical hedging after the Strait of Hormuz reopening

Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy

Samsung Galaxy M17 5G at ₹15,498: Hidden budget beast or just another overhyped Samsung phone?

Why Boeing’s $166.8 m C-17 spares win could matter more than it looks for BA stock

Why selective immune homeostasis is the bigger story behind CUE-401